chitosan has been researched along with Sarcoma 180 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Gu, J; Guo, Y; Yan, C | 1 |
| Kimura, Y; Maeda, Y | 1 |
| Chen, D; Gu, J; Qin, J; Yan, C | 1 |
| Ding, Q; Guo, Q; Ping, Q; Qu, G; Shen, Z; Sun, Y; Wu, X; Yao, Z; Yuan, S; Zhang, C; Zhou, H | 1 |
| Machida, Y; Nagai, T; Onishi, H; Sato, M; Takahara, J | 1 |
| Groves, MJ; Tian, XX | 1 |
| Kimura, Y; Okuda, H | 1 |
| Kato, Y; Machida, Y; Onishi, H | 2 |
| Kimura, Y; Okuda, H; Onoyama, M; Sera, T | 1 |
| Kimura, Y; Okuda, H; Sawai, N | 1 |
11 other study(ies) available for chitosan and Sarcoma 180
| Article | Year |
|---|---|
In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Availability; Chitosan; Drug Carriers; Fluorouracil; Injections, Intravenous; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Particle Size; Rats; Rats, Wistar; Sarcoma 180; Tissue Distribution | 2010 |
Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice.
Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Body Weight; Chitin; Chitosan; Erythrocyte Count; Intestines; Killer Cells, Natural; Leukocyte Count; Mice; Molecular Weight; Organ Size; Sarcoma 180; Solubility; Water | 2004 |
Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
Topics: Animals; Antimetabolites, Antineoplastic; Chitosan; Colloids; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Fluorouracil; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Particle Size; Sarcoma 180; Solubility; Time Factors | 2006 |
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Topics: Alkanesulfonic Acids; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Biological Availability; Carcinoma, Ehrlich Tumor; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Hemolysis; Humans; Liver Neoplasms, Experimental; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Micelles; Paclitaxel; Rats; Rats, Sprague-Dawley; Safety; Sarcoma 180; Tissue Distribution | 2008 |
In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Topics: Animals; Antibiotics, Antineoplastic; Biopolymers; Body Weight; Chemical Phenomena; Chemistry, Physical; Chitin; Chitosan; Chromatography, Gel; Delayed-Action Preparations; Glycols; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Male; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Rats, Wistar; Sarcoma 180; Succinates; Tumor Cells, Cultured | 1996 |
Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles.
Topics: Animals; Antineoplastic Agents; Cattle; Chemistry, Pharmaceutical; Chitin; Chitosan; Mice; Microscopy, Electron, Scanning Transmission; Mycobacterium; Particle Size; Polysaccharides, Bacterial; Proteoglycans; Sarcoma 180; Serum Albumin, Bovine; Time Factors | 1999 |
Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chitin; Chitosan; Digestive System; Fluorouracil; Immunocompetence; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; RNA, Neoplasm; Sarcoma 180; Spleen | 1999 |
Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer.
Topics: Animals; Biocompatible Materials; Biotransformation; Chitin; Chitosan; Half-Life; Injections, Intravenous; Male; Mice; Mice, Inbred Strains; Sarcoma 180; Tissue Distribution | 2000 |
Antitumour activity and side effects of combined treatment with chitosan and cisplatin in sarcoma 180-bearing mice.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Chelating Agents; Chitin; Chitosan; Cisplatin; Disease Models, Animal; Infusions, Parenteral; Male; Mice; Mice, Inbred ICR; Sarcoma 180 | 2000 |
Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Cell Division; Chitin; Chitosan; Drug Carriers; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mitomycin; Molecular Weight; Sarcoma 180; Solubility; Tissue Distribution | 2000 |
Antitumour activity and adverse reactions of combined treatment with chitosan and doxorubicin in tumour-bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Chitin; Chitosan; Doxorubicin; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; Organ Size; Sarcoma 180; Sucrase | 2001 |